[Clinical features of esophago-gastric varices caused by pancreatic cancer].

Nihon Shokakibyo Gakkai Zasshi

Department of Internal Medicine, Institute of Gastroenterology, Tokyo Women's Medical University, Japan.

Published: August 2008

We investigated the endoscopic and clinical features of esophageal-gastric varices in patients with pancreatic cancer. Among 96 patients who underwent upper gastrointestinal endoscopy at the time of diagnosis of pancreatic cancer, 26% were found to have varices caused by pancreatic cancer. The number of complications associated with varices of inoperable cancers was higher than that of operable cancers, probably due to the progression of pancreatic cancer. Management of these varices is important because they could reduce the quality of life and sudden bleeding could lead to interruption of chemotherapy.

Download full-text PDF

Source

Publication Analysis

Top Keywords

pancreatic cancer
16
varices caused
8
caused pancreatic
8
varices
5
pancreatic
5
[clinical features
4
features esophago-gastric
4
esophago-gastric varices
4
pancreatic cancer]
4
cancer] investigated
4

Similar Publications

A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.

CA Cancer J Clin

January 2025

Division of Medical Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA.

Poly(adenosine diphosphate ribose) polymerase (PARP) inhibitors, such as olaparib, talazoparib, rucaparib, and niraparib, comprise a therapeutic class that targets PARP proteins involved in DNA repair. Cancer cells with homologous recombination repair defects, particularly BRCA alterations, display enhanced sensitivity to these agents because of synthetic lethality induced by PARP inhibitors. These agents have significantly improved survival outcomes across various malignancies, initially gaining regulatory approval in ovarian cancer and subsequently in breast, pancreatic, and prostate cancers in different indications.

View Article and Find Full Text PDF

Pancreatic cancer is an aggressive tumor, which is often associated with a poor clinical prognosis and resistance to conventional chemotherapy. Therefore, there is a need to identify new therapeutic markers for pancreatic cancer. Although KIN17 is a highly expressed DNA‑ and RNA‑binding protein in a number of types of human cancer, its role in pancreatic cancer development, especially in relation to progression, is currently unknown.

View Article and Find Full Text PDF

RNA Modification and Digestive Tract Tumors: A Review.

Curr Med Chem

January 2025

Department of Infectious Diseases, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, 471000, Henan, China.

Gastrointestinal tumors, including colorectal and liver cancer, are among the most prevalent and lethal solid tumors. These malignancies are characterized by worsening prognoses and increasing incidence rates. Traditional therapeutic approaches often prove ineffective.

View Article and Find Full Text PDF

Background: The role of Zona pellucida glycoprotein 3 (ZP3) is unclear in pancreatic adenocarcinoma (PAAD).

Objective: This study aimed to explore the role of ZP3 in PAAD.

Methods: A comparative analysis of ZP3 gene expression was performed to discern differences between various types of cancer and PAAD, leveraging data sourced from The Cancer Genome Atlas (TCGA).

View Article and Find Full Text PDF

Even though insulinoma is the most frequent neuroendocrine tumor, it represents only 2% of pancreatic 2% of all pancreatic neoplasms. Diagnosis is relatively simple, and surgery after accurate determination of the tumors location within the pancreas is the cornerstone of its treatment. We herein report 4 patients undergoing various surgeries for benign secreting insulinomas, after extensive radiological and endoscopic exploration.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!